Author

Emmanuel Achille

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

2003 · Christophe Tournigand, Thierry André, et al. · Journal of Clinical Oncology · 2,906

Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial

2003 · Thierry André, Philippe Colin, et al. · Journal of Clinical Oncology · 261

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

2023 · Christophe Tournigand, Thierry André, et al. · Journal of Clinical Oncology · 189

Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: A french cooperative study of 1383 cases

1988 · Jean-Claude Horiot, Jacques Pigneux, et al. · International Journal of Radiation Oncology*Biology*Physics · 174

Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1

2007 · Thierry André, Emmanuel Quinaux, et al. · Journal of Clinical Oncology · 151

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

2019 · Xavier Pivot, Gilles Romieu, et al. · The Lancet · 130

A quantified approach to the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix

1987 · H. Pourquier, R. Delard, et al. · International Journal of Radiation Oncology*Biology*Physics · 71

[Adjuvant treatment of colon cancer MOSAIC study's main results].

2006 · Thierry André, Christophe Tournigand, et al. · PubMed · 43

Results of radiotherapy alone in 581 patients with stage II carcinoma of the uterine cervix

1985 · Pierre F. Combes, Nicolas J. Daly, et al. · International Journal of Radiation Oncology*Biology*Physics · 41

Phase II trial with D‐Trp‐6‐LH‐RH in prostatic carcinoma: Comparison with other hormonal agents

1986 · Georges Mathé, Leon Schwarzenberg, et al. · The Prostate · 28

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results

2001 · Thierry André, Philippe Colin, et al. · Seminars in Oncology · 21

Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients

2005 · T. Andre, E. Quinaux, et al. · Journal of Clinical Oncology · 19

Recommandations pour la pratique clinique de Saint-Paul-de-Vence

2005 · M. Namer, Joseph Gligorov, et al. · 19

5-Fluorouracil, folinic acid and oxaliplatin (FOLFOX) in poor prognosis patients with metastatic colorectal cancer

2004 · C. Tournigand, T. Andre, et al. · Journal of Clinical Oncology · 12

An oriented phase-II trial ofd-Trp6-LH-RH in patients with prostatic carcinoma

1984 · G. Mathé, M. L. Vovan, et al. · Medical Oncology and Tumor Pharmacotherapy · 11

Folfiri then folfox of folfox then folfiri in metastatic colorectal cancer (MCRC): results of a phase III trial

2001 · E. Achille, C. Tournigand, et al. · European Journal of Cancer · 6

5FU-leucovorin (5FU/LV) with or without irinotecan (CPT-11) in stages II-III rectal cancers: Preliminary safety analysis of the French Intergroup R98 phase III trial

2004 · P. Piedbois, T. André, et al. · Journal of Clinical Oncology · 3

[Radiotherapy of malpighian cancers of the anus. Interstitial curietherapy using iridium 192 for anal canal epitheliomas].

1973 · R Keiling, J M Grunenwald, et al. · PubMed · 2

Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC*

2006 · Thierry André, Christophe Tournigand, et al. · Bulletin du Cancer · 1

Combined chemoradiotherapy for invasive bladder cancer: a feasibility approach in a non selected population.

1998 · C de Pree, M S Aapro, et al. · PubMed · 1

[Long-term results of the treatment with physical agents exclusively in a series of cancers of the uterine cervix. Cooperative study of 1,383 cases].

1987 · H Pourquier, J Pigneux, et al. · PubMed · 1

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer

2020 · L. Mineur, E. François, et al. · PLoS ONE

PDF

Sur le chemin de la béatitude / Emmanuel Achille

2017 · Emmanuel . Auteur du texte Achille, Emmanuel Achille

Authors & Collaborators _ RAISE study

2015 · Palazzo F. O 'connor, Pérez Je, et al.

Safety and efficacy during first line with cetuximab in KRAS wild-type metastatic colorectal cancer (mCRC): Results of a large prospective multicenter cohort carried out by the premium French observational study.

2013 · Laurent Mineur, Gilles Seni, et al. · Journal of Clinical Oncology

Works count: 36

Citation count: 4,090

H-index: 13

I10-index: 15